The impact of metabolic syndrome on postoperative outcomes in breast oncoplastic surgery: A nationwide analysis.

INTRODUCTION: Metabolic syndrome (MetS), defined by obesity, hypertension, impaired glucose, high triglycerides, and low HDL cholesterol, affects nearly one-third of adults globally and is increasingly common among patients with breast cancer. Given…

Preview only. Read the full abstract at the source